Docetaxel Injection, Solution
Product Images NDC 43598-610

This is a description of a medication with an NDC number of 43598-610-40. The drug is Docetaxel Injection USP and it is supplied in a 4 mL single-use vial. The vial has a 2D barcode that includes the serial number, expiration date, and lot information. The medication has a concentration of 80 mg/4mL (20 mg/mL) and is ready to add to infusion solution. The medication is for intravenous infusion only and should not be used with the two-vial formulation. The one-vial formulation contains docetaxel USP, citric acid anhydrous, and polysorbate 80/dehydrated alcohol. The medication is a cytotoxic agent and should be kept out of reach of children. The medication should be stored between 2-25°C (36-77°F) and protected from light. The manufacturer is Dr. Reddy's Laboratories Limited in Visakhapatnam, India.*

NDC 43598-610-40 is a one-vial formulation of Docetaxel Injection USP, a cytotoxic agent used for Intravenous Infusion Only. It has a concentration of 80 mg/4 mL (20 mg/mL) and is manufactured by Dr. Reddy's Laboratories Limited in India. The product is ready to be added to an infusion solution. The package insert should be consulted for complete instructions.*

This is a medication guide for patients receiving docetaxel injection for various types of cancer, including breast, non-small cell lung, stomach, head and neck, and prostate cancer. The recommended dosage for oral corticosteroids is listed, with specific dates and times indicated for each treatment day. Patients are advised to follow their healthcare provider's instructions closely.*

The text contains information about a medication called "Docetaxel Injection USP" which comes in a 1 mL single-use vial with a new concentration and preparation. It is ready to add to an infusion solution and has a 2D barcode with a serial number, expiration date, and lot number, which are to be printed at the time of packing. The medication should not be mixed with the two-vial formulation, and complete instructions can be found in the package insert. The packaging dimensions are 50 x 30 x 74 mm, and the font used is Avenir Family.*

This appears to be a survival analysis plot showing the cumulative probability of survival over time (measured in months). The Logrank p-value is provided, suggesting that there is a statistically significant difference in survival rates between groups being compared. However, without additional context or information, it is difficult to determine the specifics of the analysis being conducted or the interpretation of the results.*

This is a graph representing the cumulative probability of overall survival over time in months. The y-axis shows the cumulative probability from 0 to 1. The x-axis shows the survival time in months. The graph also includes a log-rank p-value of 0.138 indicating a statistical difference between survival probabilities.*